These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6405480)

  • 1. Pre-exposure prophylaxis of viral hepatitis with immune serum globulin in an endemic area. A trial in field units of the Israel Defence Forces.
    Kark JD
    Scand J Infect Dis; 1983; 15(1):3-6. PubMed ID: 6405480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The three-year incidence of non-B viral hepatitis morbidity in a controlled trial of pre-exposure immune serum globulin prophylaxis.
    Kark JD; Witztum E; Mazkin H; Nili E; Danon YL
    Infection; 1984; 12(4):251-5. PubMed ID: 6386693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-exposure prophylaxis with immune serum globulin for prevention of viral hepatitis in army recruits.
    Kark JD
    J Epidemiol Community Health; 1982 Sep; 36(3):176-82. PubMed ID: 6754845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: a three-year prospective study.
    Lerman Y; Shohat T; Ashkenazi S; Almog R; Heering SL; Shemer J
    Clin Infect Dis; 1993 Sep; 17(3):411-4. PubMed ID: 8218682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological hepatitis A virus infections and ratio of clinical to serological infections in a controlled trial of pre-exposure prophylaxis with immune serum globulin.
    Kark JD; Bar-Shany S; Shor S; Merlinski L; Nili E
    J Epidemiol Community Health; 1985 Jun; 39(2):117-22. PubMed ID: 3891900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-benefit of mass prophylaxis with immune serum globulin to control waterborne hepatitis A: a case study.
    Egoz N
    Isr J Med Sci; 1986; 22(3-4):277-82. PubMed ID: 3091532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active versus passive immunization against hepatitis A in the Israel defence forces: a cost-benefit analysis.
    Gillis D; Yetiv N; Gdalevich M; Mimouni D; Ashkenazi I; Shpilberg O; Eldad A; Shemer J
    Vaccine; 2000 Jul; 18(26):3005-10. PubMed ID: 10825603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thirty years of experience with infectious hepatitis prevention in the Israel Defence Forces.
    Heering SL; Shohat T; Lerman Y
    Mil Med; 1992 Oct; 157(10):530-2. PubMed ID: 1454175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute non-B hepatitis in the Israel Defence Forces: comparison of some epidemiologic features before and after the usage of preexposure immune serum globulin prophylaxis.
    Matzkin H
    Hepatology; 1987; 7(6):1330-2. PubMed ID: 3119454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent effect of immune serum globulin prophylaxis in the military on viral hepatitis incidence in the civilian population in Israel.
    Green MS; Block C
    J Epidemiol Community Health; 1989 Jun; 43(2):187-90. PubMed ID: 2592909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trends in epidemiology of hepatitis in the Israel Defense Forces-- direction over several years].
    Gdalevich M; Gillis D; Mimouni D; Grotto I; Shpilberg O
    Harefuah; 2000 May; 138(9):755-7, 806, 805. PubMed ID: 10883230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to trivalent oral poliovirus vaccine with and without immune serum globulin in young adults in Israel in 1988.
    Green MS; Melnick JL; Cohen D; Slepon R; Danon YL
    J Infect Dis; 1990 Oct; 162(4):971-4. PubMed ID: 2169502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin.
    Conrad ME; Lemon SM
    J Infect Dis; 1987 Jul; 156(1):56-63. PubMed ID: 3110307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine testing for IgG antibodies against hepatitis A virus in Israel.
    Samuels N
    BMC Public Health; 2005 Jun; 5():60. PubMed ID: 15935104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of immune serum globulin (ISG) against hepatitis A infection in a natural epidemic.
    Hall WT; Madden DL; Mundon FK; Brandt DE; Clarke NA
    Am J Epidemiol; 1977 Jul; 106(1):72-5. PubMed ID: 879162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin prophylaxis against hepatitis A among Swedish UN soldiers in an endemic region.
    Weiland O; Berg JV; Bäck E; Lundbergh P
    Infection; 1979; 7(5):223-5. PubMed ID: 511340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program.
    Belmaker I; Dukhan L; Yosef Y; Leventhal A; Dagan R
    Pediatr Infect Dis J; 2007 Jan; 26(1):36-40. PubMed ID: 17195703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A antibody prevalence among young adults in Israel--the decline continues.
    Gdalevich M; Grotto I; Mandel Y; Mimouni D; Shemer J; Ashkenazi I
    Epidemiol Infect; 1998 Oct; 121(2):477-9. PubMed ID: 9825802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A and the American traveler.
    Wolfe MS
    J Infect Dis; 1995 Mar; 171 Suppl 1():S29-32. PubMed ID: 7876645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.